Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumors.
Sci Adv. 2021 Jun 9;7(24):eabi5781. doi: 10.1126/sciadv.abi5781. Print 2021 Jun.
Sci Adv. 2021.
PMID: 34108220
Free PMC article.